Concepedia

Midas M. Kuilman

MM

3

Publications

50

Citations

3

H-Index

2022

Active since

Affiliations

Agendia (Netherlands)(Current)

University of California, San Francisco

Midas M. Kuilman is an author at Agendia (Netherlands) specializing in medicine, oncology, and tumor microenvironment.

Top concepts

MedicineOncologyImmunologyBreast CancerImmunotherapyTumor ImmunityRadiation OncologyImmune SurveillanceTumor MicroenvironmentAllergy

Publications per year

2022–2023

3

Publications

3

The ImPrint immune signature to identify patients with high-risk early breast cancer who may benefit from PD1 checkpoint inhibition in I-SPY2.

Lorenza Mittempergher, Midas M. Kuilman, Andrei Barcaru et al. · Journal of Clinical Oncology · 2022 · 23 citations

Breast Oncology, Immunology, Pathology +23

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance

Midas M. Kuilman, Architha Ellappalayam, Andrei Barcaru et al. · Breast Cancer Research and Treatment · 2022 · 15 citations · Full text

Biomarkers predicting response to 5 immunotherapy arms in the neoadjuvant I-SPY2 trial for early-stage breast cancer (BC): Evaluation of immune subtyping in the response predictive subtypes (RPS).

Denise M. Wolf, Christina Yau, Michael J. Campbell et al. · Journal of Clinical Oncology · 2023 · 12 citations

Breast Oncology, Immunology, Immunoediting +21

Rows per page

1–3 of 3